Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Gillard

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Drug Metabolism Reviews|July 16, 2009
From pharmacokinetics to therapeuticsMartin K Church, Michel Gillard, Maria Laura Sargentini-Maier, et al.
European Journal of Pharmacology|October 14, 2003
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell linesBruno Fuks, Michel Gillard, Philippe Michel, et al.
Epilepsia|June 3, 2009
Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetamRafal M Kaminski, Michel Gillard, Karine Leclercq, et al.
Molecular Pharmacology|January 1, 2005
Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptorMartijn Bruysters, Aldo Jongejan, Michel Gillard, et al.
Neuropharmacology|January 22, 2008
SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsyRafal M Kaminski, Alain Matagne, Karine Leclercq, et al.
Journal of Biomolecular Screening|November 20, 2015
Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-MethyltransferaseMartha Kimos, Maggi Burton, David Urbain, et al.
Plos One|August 8, 2009
H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cellsAnne-France Petit-Bertron, François Machavoine, Marie Paule Defresne, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPDJean-Philippe Starck, Laurent Provins, Bernard Christophe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2017
The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidasesCéline Vermeiren, Philippe Motte, Delphine Viot, et al.
European Journal of Pharmacology|March 23, 2004
Mutational analysis of the histamine H1-receptor binding pocket of histaprodifensMartijn Bruysters, Heinz H Pertz, Aloys Teunissen, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Drug Metabolism Reviews|July 16, 2009
From pharmacokinetics to therapeuticsMartin K Church, Michel Gillard, Maria Laura Sargentini-Maier, et al.
European Journal of Pharmacology|October 14, 2003
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell linesBruno Fuks, Michel Gillard, Philippe Michel, et al.
Epilepsia|June 3, 2009
Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetamRafal M Kaminski, Michel Gillard, Karine Leclercq, et al.
Molecular Pharmacology|January 1, 2005
Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptorMartijn Bruysters, Aldo Jongejan, Michel Gillard, et al.
Neuropharmacology|January 22, 2008
SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsyRafal M Kaminski, Alain Matagne, Karine Leclercq, et al.
Journal of Biomolecular Screening|November 20, 2015
Development of an HTRF Assay for the Detection and Characterization of Inhibitors of Catechol-O-MethyltransferaseMartha Kimos, Maggi Burton, David Urbain, et al.
Plos One|August 8, 2009
H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cellsAnne-France Petit-Bertron, François Machavoine, Marie Paule Defresne, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPDJean-Philippe Starck, Laurent Provins, Bernard Christophe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2017
The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidasesCéline Vermeiren, Philippe Motte, Delphine Viot, et al.
European Journal of Pharmacology|March 23, 2004
Mutational analysis of the histamine H1-receptor binding pocket of histaprodifensMartijn Bruysters, Heinz H Pertz, Aloys Teunissen, et al.
Pageof 6